Neutrophil CD64 as a Marker of Bacterial Infection in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Immunological Investigations

Volumn 45, Issue 6, 2016, Pages 490-503

  Qian, Wei ^a   Huang, Gao Zhong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Antibiotic treatment; diagnosis; efficacy; peripheral blood

Indexed keywords

ALKALINE PHOSPHATASE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; BRONCHODILATING AGENT; C REACTIVE PROTEIN; CD64 ANTIGEN; CEPHALOSPORIN DERIVATIVE; EXPECTORANT AGENT; GLUCOCORTICOID; PENICILLIN DERIVATIVE; PROCALCITONIN; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; CALCITONIN; FC RECEPTOR;

ADULT; AGED; ANTIBIOTIC THERAPY; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BLOOD GAS ANALYSIS; BLOOD SAMPLING; BODY TEMPERATURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CRACKLE; DISEASE DURATION; DISEASE EXACERBATION; DRUG EFFICACY; EARLY DIAGNOSIS; FEMALE; HOSPITAL ADMISSION; HOSPITAL COST; HUMAN; LENGTH OF STAY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUTROPHIL; NEUTROPHIL COUNT; OXYGEN THERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; RESPIRATORY TRACT INFECTION; SMOKING; SPUTUM CULTURE; ACUTE DISEASE; BLOOD; CASE CONTROL STUDY; COMPLICATION; DRUG EFFECTS; ECONOMICS; EVIDENCE BASED MEDICINE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; IMMUNOLOGY; LYMPHOCYTE; METABOLISM; MICROBIOLOGY; PATHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ACUTE DISEASE; AGED; ANTI-BACTERIAL AGENTS; BIOMARKERS; C-REACTIVE PROTEIN; CALCITONIN; CASE-CONTROL STUDIES; EVIDENCE-BASED MEDICINE; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LENGTH OF STAY; LEUKOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, IGG;

EID: 84969835124     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820139.2016.1177540     Document Type: Article

References (40)

1. R.Agarwal, D.N.Schwartz (2011). Procalcitonin to guide duration of antimicrobial therapy in intensive care units: A systematic review. Clin Infect Dis 53(3), 379–87.
2. N.R.Anthonisen, J.Manfreda, C.P.W.Warren, et al. (1987). Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med, 106(2), 196–204.
3. F.Blasi, M.Mantero, S.Aliberti (2012). Antibiotics as immunomodulant agents in COPD. Curr Opin Pharmacol, 12(3), 293–9.
4. B.Butorac-Petanjek, M.J.Parnham, S.Popović-Grle (2010). Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD). J Chemother, 22(5), 291–7.
5. B.R.Celli, P.J.Barnes (2007). Exacerbations of chronic obstructive pulmonary disease. Eur Respir J, 29(6), 1224–38.
6. D.D.Danikas, M.Karakantza, G.L.Theodorou, et al. (2008). Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression. Clin Exp Immunol, 154(1), 87–97.
7. A.Daryapeyma, G.Pedersen, E.Laxdal, et al. (2009). Neutrophil CD64 as a marker for postoperative infection: A pilot study. Eur J Vasc Endovasc Surg, 38(1), 100–3.
8. D.Dev, E.Wallace, R.Sankaran, et al. (1998). Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease. Respir Med, 92(4), 664–7.
9. A.Dimoula, O.Pradier, Z.Kassengera, et al. (2014). Serial determinations of neutrophil CD64 expression for the diagnosis and monitoring of sepsis in critically ill patients. Clin Infect Dis, 58(6), 820–9.
10. F.B.Du, W.C.Yang, Z.B.Lei (2013). Value of neutrophil CD64 index in guiding the therapy for acute exacerbation of chronic obstructive pulmonary disease. Anhui Med Pharm J, 17(4), 596–8.
11. S.Elawady, S.K.Botros, A.E.Sorour, et al. (2014). Neutrophil CD64 as a diagnostic marker of sepsis in neonates. J Invest Med, 62(3), 644–9.
12. D.N.Gilbert (2011). Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis, 52(Suppl 4), S346–50.
13. N.J.Goulding, S.M.Knight, J.L.Godolphin, P.M.Guyre (1992). Increase in neutrophil Fc gamma receptor I expression following interferon gamma treatment in rheumatoid arthritis. Ann Rheum Dis, 51(4), 465–8.
14. P.M.Guyre, A.S.Campbell, W.D.Kniffin, M.W.Fanger (1990). Monocytes and polymorphonuclear neutrophils of patients with streptococcal pharyngitis express increased numbers of type I IgG Fc receptors. J Clin Invest, 86(6), 1892–6.
15. C.M.Herra, C.T.Keane, A.Whelan (1996). Increased expression of Fcγ receptors on neutrophils and monocytes may reflect ongoing bacterial infection. J Med Microbiol 44(2), 135–40.
16. J.J.Hoffmann (2009). Neutrophil CD64: A diagnostic marker for infection and sepsis. Clin Chem Lab Med 47(8), 903–16.
17. J.C.Hogg (2004). Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet, 364(9435), 709–21.
18. J.M.Kerst, J.G.Van de Winkel, A.H.Evans, et al. (1993). Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells. Blood, 81(6), 1457–64.
19. M.Kolackova, M.Kudlova, P.Kunes, et al. (2008). Early expression of FcγRI (CD64) on monocytes of cardiac surgical patients and higher density of monocyte anti-inflammatory scavenger CD163 receptor in “on-pump” patients. Mediators Inflamm, Article ID 235461: 1–6.
20. M.Korppi, L.Kröger, M.Laitinen (1993). White blood cell and differential counts in acute respiratory viral and bacterial infections in children. Scand J Infect Dis, 25(4), 435–40.
21. W.MacNee (2005). Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2(4), 258–66.
22. W.Mao, Y.Jiang, L.Ouyang, et al. (2014). Early diagnostic values of CD64 and CD11b indices of peripheral white blood cells for acute exacerbation of chronic obstructive pulmonary disease in older adults. Chin J Cell Mol Immunol, 30(11), 1201–4.
23. C.D.Mathers, D.Loncar (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med, 3(11), e442.
24. P.C.Ng, K.Li, R.P.O.Wong, et al. (2002). Neutrophil CD64 expression: a sensitive diagnostic marker for late-onset nosocomial infection in very low birthweight infants. Pediatr Res, 51(3), 296–303.
25. F.Nimmerjahn, J.V.Ravetch (2006). Fcγ receptors: Old friends and new family members. Immunity, 24(1), 19–28.
26. F.Pagella, M.De Amici, E.Matti, et al. (2013). CD64 expression on monocytes in children with adenoid hypertrophy. Asian Pac J Allergy Immunol, 31(2), 132–7.
27. C.Peng, C.Tian, Y.Zhang, et al. (2013). C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease. Am J Med Sci, 345(3), 190–4.
28. K.F.Rabe, S.Hurd, A.Anzueto, et al. (2007). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care, 176(6), 532–55.
29. S.Radaev, P.Sun (2002). Recognition of immunoglobulins by Fcγ receptors. Mol Immunol, 38(14), 1073–83.
30. M.B.Rothberg, P.S.Pekow, M.Lahti, et al. (2010). Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease. JAMA, 303(20), 2035–42.
31. S.Sethi (2005). Pathogenesis and treatment of acute exacerbations of chronic obstructive pulmonary disease. Semin Respir Crit Care Med, 26(2), 192–203.
32. P.Sexton, P.Black, L.Wu, et al. (2014). Chronic obstructive pulmonary disease in non-smokers: A case-comparison study. COPD, 1(1), 2–9.
33. I.Streimish, M.Bizzarro, V.Northrup, et al. (2014). Neutrophil CD64 with hematologic criteria for diagnosis of neonatal sepsis. Am J Perinatol 31(1), 21–30.
34. S.Tanaka, J.Nishino, T.Matsui, et al. (2009). Neutrophil CD64 expression in the diagnosis of local musculoskeletal infection and the impact of antibiotics. J Bone Joint Surg Br, 91(9), 1237–42.
35. H.Tanrıverdi, T.Örnek, F.Erboy, et al. (2015). Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD. Wien Klin Wochenschr, 127(19–20), 1–8.
36. J.Vestbo, S.S.Hurd, A.G.Agusti, et al. (2013). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care, 187(4), 347–65.
37. Q.Q.Yu, H.P.Wang, Z.M.Zhai, Y.M.Zhao (2011). Clinical significance of determination of neutrophil CD64 mean fluorescence intensity index using flow cytometry in diagnosis of infection diseases. Clin Focus 26(5), 383–7.
38. L.X.Zhang, J.Ye, Y.B.Chen, et al. (2013). The effect of CD33 expression on inflammatory response in chronic obstructive pulmonary disease. Immunol Invest, 42(8), 701–10.
39. N.Zhong, C.Wang, W.Yao, et al. (2007). Prevalence of chronic obstructive pulmonary disease in China: A large, population-based survey. Am J Respir Crit Care, 176(8), 753–60.
40. Y.Zhu, X.Cao, K.Zhang, et al. (2014). Delta mean neutrophil volume (ΔMNV) is comparable to procalcitonin for predicting postsurgical bacterial infection. J Clin Lab Anal 28(4), 301–5.